RXRX Recursion Pharmaceuticals, Inc. Class A Common Stock BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) Best Biotech Stocks 2026 →

Recursion Pharmaceuticals (RXRX) Stock: Buy, Sell, or Hold?

$3.55
-0.26 (-6.70%) ▼
5d: -3.53% 30d: -11.47% 90d: +7.9%
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (77%)
Quality Score
54/100
Position
OVERSOLD
30-Day Fair Range
$3.58 – $4.26
Position: OVERSOLD
Forward P/E & Valuation
-4.3x
Next 12M consensus est.
Wall Street Target
$7.32
+106.1% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$3.42 / $4.52
Trend: Uptrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: RXRX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Smart Money Accumulation

Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →

Signal fired Nov 3, 2026 at $3.68 · last confirmed Nov 5, 2026

Strength: 6.8/10

Get Alerted When RXRX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: RXRX is currently trading at $3.55, which is considered oversold relative to its 30-day fair value range of $3.58 to $4.26.

Technical Outlook: Technically, RXRX is in a uptrend. Immediate support is located at $3.42, while resistance sits at $4.51. Short-term momentum is weak, with the stock down 6.7% recently.

Market Sentiment: The stock scores a mixed 46/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $7.32 (+106.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $3.58 - $4.26
Company Quality Score 54/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 77.4%

Trading Range & Key Levels

30-Day Trading Range $3.58 - $4.26
Current vs Trading Range OVERSOLD
Support Level $3.42
Resistance Level $4.52
Current Trend Uptrend
Technical data as of Nov 10, 2026

Protect Your Profits

Holding RXRX? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (46/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-6.7%)
  • BULLISH: Trading 106.1% below Wall St target ($7.32)
  • NEUTRAL: Bottoming setup forming (46/100) — watch for confirmation

Fundamental Context

Forward P/E (Next Year Est.) -4.30
Wall Street Target $7.32 (+106.1%)
Revenue Growth (YoY) 258.5%
Share RXRX Analysis

Share this live RXRX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (RXRX)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 9, 2026
Daily AI digest
AI Retail Discussion Summary: A bullish StockTwits user expresses intent to purchase more shares of $RXRX, suggesting a bullish outlook.
Key Retail Themes: Buyer sentiment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:38 AM ET
Data refreshes hourly during market hours. Next update: 9:38 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for RXRX.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ARGX
argenx NV ADR
STRONG BUY
23 analysts
$1147 47 HOLD
KYMR
Kymera Therapeutics Inc
STRONG BUY
24 analysts
$145 31 SELL
BNTX
BioNTech SE
BUY
21 analysts
$114 63 BUY
IRD
Opus Genetics, Inc.
STRONG BUY
18 analysts
$13 43 HOLD
MRUS
Merus BV
STRONG BUY
17 analysts
$97 39 SELL

Advanced RXRX Option Strategies

Professional options setups generated by AI based on today's RXRX price and gamma walls.

Iron Condor Bull Call Bear Put Collar

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive RXRX Research Pages
RXRX Technical Chart RXRX Price Prediction RXRX Intrinsic Value DCF RXRX Earnings Date Why is RXRX Moving Today? RXRX Investment Advisor RXRX Fair Price Analyzer RXRX Options Chain RXRX Options Advisor RXRX Options Analysis RXRX Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals